Biofil Chemicals and Pharmaceuticals Limited (BOM:524396)
India
· Delayed Price · Currency is INR 30.31
-1.19 (-3.78%)
At close: Mar 9, 2026
BOM:524396 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 2.55 | 22.84 | 0.38 | 1.45 | 4.41 | Upgrade
|
| Cash & Short-Term Investments | 3.59 | 2.55 | 22.84 | 0.38 | 1.45 | 4.41 | Upgrade
|
| Cash Growth | 63.21% | -88.82% | 5973.14% | -74.05% | -67.11% | 72.07% | Upgrade
|
| Accounts Receivable | - | 383.15 | 330.29 | 205.03 | 71.74 | 172.18 | Upgrade
|
| Other Receivables | - | - | - | - | 2.05 | 0.66 | Upgrade
|
| Receivables | - | 383.15 | 330.29 | 205.03 | 73.79 | 172.84 | Upgrade
|
| Inventory | - | 36.9 | 28.49 | 14.81 | 15.41 | 54.3 | Upgrade
|
| Prepaid Expenses | - | 0.09 | 0.09 | 0.96 | 2.48 | 3.08 | Upgrade
|
| Other Current Assets | - | 2.85 | 2.37 | 2.37 | - | - | Upgrade
|
| Total Current Assets | - | 425.54 | 384.08 | 223.54 | 93.13 | 234.62 | Upgrade
|
| Property, Plant & Equipment | - | 83.45 | 86.24 | 90.01 | 94.19 | 97.77 | Upgrade
|
| Other Long-Term Assets | - | 0.62 | 0.51 | 0.51 | -0 | -0 | Upgrade
|
| Total Assets | - | 509.6 | 470.83 | 314.06 | 187.32 | 332.38 | Upgrade
|
| Accounts Payable | - | 309.88 | 275.55 | 126.5 | 5.96 | 158.52 | Upgrade
|
| Accrued Expenses | - | 0.32 | 0.31 | 0.37 | 0.66 | 0.37 | Upgrade
|
| Current Portion of Long-Term Debt | - | 4.71 | 4.39 | 5.22 | 4.65 | 4.3 | Upgrade
|
| Current Income Taxes Payable | - | 2.1 | 2.4 | 2.3 | 2.71 | 3.28 | Upgrade
|
| Other Current Liabilities | - | 1.47 | 2.59 | 2.86 | 0.97 | 1.07 | Upgrade
|
| Total Current Liabilities | - | 318.48 | 285.25 | 137.26 | 14.95 | 167.53 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 3.31 | 3.55 | 3.79 | 4 | 3.56 | Upgrade
|
| Other Long-Term Liabilities | - | 0 | - | - | - | - | Upgrade
|
| Total Liabilities | - | 321.79 | 288.8 | 141.04 | 18.95 | 171.09 | Upgrade
|
| Common Stock | - | 162.74 | 162.74 | 162.74 | 162.74 | 162.74 | Upgrade
|
| Additional Paid-In Capital | - | 83.33 | 83.33 | 83.33 | 83.33 | 83.33 | Upgrade
|
| Retained Earnings | - | -113.66 | -119.44 | -128.46 | -133.1 | -140.18 | Upgrade
|
| Comprehensive Income & Other | - | 55.4 | 55.4 | 55.4 | 55.4 | 55.4 | Upgrade
|
| Shareholders' Equity | 213.04 | 187.81 | 182.03 | 173.02 | 168.38 | 161.29 | Upgrade
|
| Total Liabilities & Equity | - | 509.6 | 470.83 | 314.06 | 187.32 | 332.38 | Upgrade
|
| Total Debt | 0.2 | 4.71 | 4.39 | 5.22 | 4.65 | 4.3 | Upgrade
|
| Net Cash (Debt) | 3.39 | -2.16 | 18.45 | -4.85 | -3.2 | 0.11 | Upgrade
|
| Net Cash Per Share | 0.21 | -0.13 | 1.13 | -0.30 | -0.20 | 0.01 | Upgrade
|
| Filing Date Shares Outstanding | 15.84 | 16.27 | 16.27 | 16.27 | 16.27 | 16.27 | Upgrade
|
| Total Common Shares Outstanding | 15.84 | 16.27 | 16.27 | 16.27 | 16.27 | 16.27 | Upgrade
|
| Working Capital | - | 107.06 | 98.83 | 86.29 | 78.18 | 67.09 | Upgrade
|
| Book Value Per Share | 12.74 | 11.54 | 11.19 | 10.63 | 10.35 | 9.91 | Upgrade
|
| Tangible Book Value | 213.04 | 187.81 | 182.03 | 173.02 | 168.38 | 161.29 | Upgrade
|
| Tangible Book Value Per Share | 12.74 | 11.54 | 11.19 | 10.63 | 10.35 | 9.91 | Upgrade
|
| Land | - | 44.96 | 44.96 | 44.96 | 44.96 | 44.96 | Upgrade
|
| Buildings | - | 30.12 | 30.12 | 29.9 | 29.8 | 29.8 | Upgrade
|
| Machinery | - | 42.43 | 41.43 | 41.42 | 41.41 | 40.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.